Liver resection and ablation for metastatic melanoma: A single center experience.
Fiche publication
Date publication
juin 2015
Journal
Journal of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr NARDIN Charlée
Tous les auteurs :
Doussot A, Nardin C, Takaki H, Litchman TD, D'Angelica MI, Jarnagin WR, Postow MA, Erinjeri JP, Kingham TP
Lien Pubmed
Résumé
The median survival for patients with stage IV metastatic melanoma is usually limited to approximately 1 year. In the case of liver metastasis, resection and ablation can achieve long-term survival. This study aimed to describe the outcomes after liver resection or ablation for metastatic melanoma to the liver and identify preoperative prognostic factors.
Mots clés
ablation therapy, extrahepatic disease, liver resection, melanoma liver metastasis
Référence
J Surg Oncol. 2015 06;111(8):962-8